01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Product Type

07.1 Polysaccharide Vaccines

07.2 Conjugate Vaccines

08. Market Assessment of Top Pneumococcal

Vaccines

08.1 Synflorix

08.2 Pneumovax 23

08.3 Prevnar

09. Geographical Segmentation

09.1 Pneumococcal Vaccines Market in US 2013-2018

09.1.1 Market Size and Forecast

10. Rate of Incidence and Prevalence

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Market Share Analysis 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 GlaxoSmithKline

19.1.1 Key Facts

19.1.2 Business Overview

19.1.3 Business Segmentation

19.1.4 Business Segmentation by Revenue 2012 and 2013

19.1.5 Sales by Geography

19.1.6 Pipeline Products

19.1.7 Business Strategy

19.1.8 Key Information

19.1.9 SWOT Analysis

19.2 Merck

19.2.1 Key Facts

19.2.2 Business Overview

19.2.3 Business Segmentation by Revenue 2013

19.2.4 Business Segmentation by Revenue 2012 and 2013

19.2.5 Sales by Geography

19.2.6 Business Strategy

19.2.7 Key Developments

19.2.8 SWOT Analysis

19.3 Pfizer

19.3.1 Key Facts

19.3.2 Business Overview

19.3.3 Business Segmentation

19.3.4 Business Segmentation by Revenue

19.3.5 Business Segmentation by Revenue 2012 and 2013

19.3.6 Sales by Geography

19.3.7 Business Strategy

19.3.8 Key Developments

19.3.9 SWOT Analysis

20. Other Reports in this Series